Overview

University of Missouri has partnered with Allied Minds to create LifeScreen, Inc. to develop and commercialize a new non-invasive breast cancer diagnostic test. This new test will screen for specific biomarkers present in nipple aspirate fluid (NAF) when a person has cancer. The technology will be marketed to hospitals and clinics worldwide, as well as packaged into a home test. LifeScreen’s underlying science has been developed by Drs. Ed Sauter, Sue Deutscher, and Tom Quinn from the University of Missouri-Columbia.